Name: Eleventh MENACTRIMS Congress
Start: 2026-12-04
End: 2026-12-05
Location: InterContinental Dubai Festival City by IHG

OVERVIEW

Eleventh Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS) Congress is organized by Lumina Organizers and will be held from Dec 04 - 05, 2026 at InterContinental Dubai Festival City by IHG, Dubai, United Arab Emirates.

Description:
This premier neurology event will feature comprehensive scientific sessions covering multiple sclerosis (MS) research, neuroimmunology, advances in MS treatment, and patient-centered care. The congress will bring together leading experts in the field to discuss cutting-edge developments and the latest clinical applications in MS treatment and research. Attendees will have the opportunity to submit abstracts and participate in engaging panel discussions, hands-on workshops, and networking sessions designed to foster collaboration within the neurology community.

KEY DATES

22 Mar, 2026

Registrations Open

04 Dec, 2026

Event Start Date

05 Dec, 2026

Event End Date

ACCREDITATION & CREDITS

MENACTRIMS is granted CME (Category 1) by Dubai Health.

12 CME

TARGET AUDIENCE

PhysicianCliniciansResearchersNeurologistsMedical StudentsPaediatric Neurologists

SPECIALITIES

Research and Clinical ResearchNeurology

SUGGESTED HOTELS

CONFERENCE VENUE

InterContinental Dubai Festival City by IHG

Dubai Festival City

REFUND, CANCELLATION POLICY & DISCLAIMER

Registrations are non-refundable, however names can be replaced. Lumina does not offer refunds for cancellations or no-shows.

Lumina reserves the right to modify or cancel any or all activities associated with this meeting due to unforeseen circumstances. In the event that we have to unexpectedly cancel the meeting, the registration fee, less a processing charge, will be returned to each registrant.

DISCLAIMER

The relationship between the official institutions endorsing this event and the sponsoring organizations of an event or event-related item do not represent exclusive agreements between the institutions and the organization, nor do they suggest that institutions endorse the programs, products or services of the organization.